A study on T2D and control subjects undergoing a hyperinsulinemic clamp found that prothrombotic platelet proteins, namely P-selectin, platelet factor 4, platelet glycoprotein VI, and PAI-1, were elevated in T2D subjects in comparison to control subjects [42], making them more susceptible to thromboembolic events. The gene discussed is GP6; the disease is type 2 diabetes mellitus.